Early Engagement with HTA Bodies
In-depth guide to successful early HTA engagement.
CertaraMay 10, 2021
Evidence generation in Europe- How valuable is the French National administrative health data (SNDS)
Evidence generation in Europe- How valuable is the French National administrative health data (SNDS)
Watch this presentation to learn • Overview of the SNDS and the key working practices…
CertaraMay 7, 2021
Economic and Clinical Burden of Virus-Associated Hemorrhagic Cystitis in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation in the United States
Authors: Joseph McGuirk, Clint Divine, Seung Hyun Moon, Aastha Chandak, Zhiji Zhang, Genovefa A. Papanicolaou…
CertaraApril 8, 2021
Legislators: Bring all stakeholders to the table to lower drug costs
BY ROMAN CASCIANO, OPINION CONTRIBUTOR — 03/29/21 05:30 PM EDT No one is happy with the…
CertaraMarch 30, 2021
Strategic Evidence & Value Communication Symposium
Join us on Wednesday, April 21, 2021, from12:00 PM – 2:00 PM EDT for Certara’s…
CertaraMarch 26, 2021
Getting Gene Therapies to Patients
This blog discusses the challenges that drug developers face in getting patients access to cell…
CertaraFebruary 16, 2021
Early Value Assessment in Gene Therapy Clinical Trial Design
A global biotechnology company engineering precision genetic medicine for rare diseases was in need of…
CertaraFebruary 12, 2021
Getting Real with RWE
By Taren Grom Real-world evidence, important for regulatory decision-making, is beginning to touch all areas…
CertaraNovember 20, 2020
SNDS: Strengths, Limitations and Perspectives for the Largest and Richest Real-World Database in EU
In this webinar, our experts provided an overview of the SNDS and the key working…
CertaraOctober 20, 2020
